Growth factors in steroid-responsive prostatic tumor cells
Tóm tắt
Từ khóa
Tài liệu tham khảo
Hodges, 1979, Hormone therapy in prostatic cancer, Vol. II, 57
Wilding, 1992, The importance of steroid hormones in prostate cancer, Cancer Surv, 14, 113
Crawford, 1995, Endocrine therapy of prostate cancer: optimal form and appropriate timing, J Clin Endocr Metab, 80, 1062, 10.1210/jc.80.4.1062
Connolly, 1990, Production of epidermal growth factor and transforming growth factor-α by the androgen-responsive LNCaP human cancer cell line, Prostate, 16, 209, 10.1002/pros.2990160304
MacGrogan, 1992, Expression of nerve growth factor and nerve growth factor receptor genes in human tissues and in prostatic adenocarcinoma cell lines, J Neurochem, 59, 1381, 10.1111/j.1471-4159.1992.tb08451.x
Knabbe, 1993, Hormonal regulation of transforming growth factor β-2 expression in human prostate cancer, J Steroid Biochem Mol Biol, 47, 137, 10.1016/0960-0760(93)90067-7
Liu, 1993, Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-α (TGF-α) and epidermal growth factor (EGF)TGF-α receptor, J Clin Endocr Metab, 77, 1472, 10.1210/jc.77.6.1472
Sehgal, 1994, Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer, 91, 4673
Helle, 1995, Insulin-like growth factors in breast and prostatic cancer, Endocr-Rel Cancer, 2, 153, 10.1677/erc.0.0020153
Schuurmans, 1991, Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones, J Steroid Biochem Mol Biol, 40, 193, 10.1016/0960-0760(91)90182-5
Ravenna, 1995, Androgenic and antiandrogenic control on epidermal growth factor, epidermal growth factor receptor, and androgen receptor expression in human prostate cancer cell line LNCaP, Prostate, 26, 290, 10.1002/pros.2990260604
Limonta, 1993, Expression of luteinizing hormone-releasing hormone mRNA in the human prostatic cancer cell line LNCaP, J Clin Endocr Metab, 76, 797, 10.1210/jc.76.3.797
Limonta, 1992, Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP, J Clin Endocr Metab, 75, 207, 10.1210/jc.75.1.207
Qayum, 1990, The effects of gonadotrophin releasing hormone analogues in prostatic cancer cell lines, Br J Cancer, 62, 96, 10.1038/bjc.1990.236
Horoszewicz, 1983, LNCaP model of human prostatic carcinoma, Cancer Res, 43, 1809
Henttu, 1992, Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line, Endocrinology, 130, 766, 10.1210/en.130.2.766
Veldscholte, 1992, The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens, J Steroid Biochem Mol Biol, 41, 665, 10.1016/0960-0760(92)90401-4
Trapman, 1988, Cloning, structure and expression of a cDNA encoding the human androgen receptor, Biochem Biophys Res Commun, 153, 241, 10.1016/S0006-291X(88)81214-2
Brinkmann, 1989, The human androgen receptor: domain, structure, genomic organization and regulation of expression, J Steroid Biochem, 34, 307, 10.1016/0022-4731(89)90098-8
Krongrad, 1991, Androgen increases androgen receptor protein while decreasing recepton mRNA in LNCaP cells, Mol Cell Endocrinol, 76, 79, 10.1016/0303-7207(91)90262-Q
Chirgwin, 1979, Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease, Biochemistry, 18, 5294, 10.1021/bi00591a005
Chang, 1988, Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors, 85, 7211
Mizokami, 1992, Regulation of androgen receptor by androgen and epidermal growth factor in a human prostatic cancer cell line, LNCaP, Endocrinol Jpn, 39, 235, 10.1507/endocrj1954.39.235
MacDonald, 1992, Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines, Br J Cancer, 65, 177, 10.1038/bjc.1992.37
Limonta, 1994, The EGFTGFα system as an autocrine growth stimulatory loop in LNCaP cells, Endocr-Rel Cancer, 3, 5
Fekete, 1989, Receptors for luteinizing hormone-releasing hormone, somatostatin, prolactin, and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasia, Prostate, 14, 191, 10.1002/pros.2990140302
Ullrich, 1990, Signal transduction by receptors with tyrosine kinase activity, Cell, 61, 203, 10.1016/0092-8674(90)90801-K
Laemmli, 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature, 227, 680, 10.1038/227680a0
Lee, 1991, Effects of epidermal growth factor and analogues of luteinizing hormonereleasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates in various tumors, 88, 1656